Literature DB >> 22024355

BMP activated Smad signaling strongly promotes migration and invasion of hepatocellular carcinoma cells.

Ulrike Maegdefrau1, Anja-Katrin Bosserhoff.   

Abstract

Several of the different bone morphogenetic proteins (BMPs) are involved in development and progression of specific tumors. For hepatocellular carcinoma (HCC) only BMP4 and BMP6 are described to be important for carcinogenesis. However, up to now neither the influence of other BMPs on tumor progression, nor the responsible signaling pathways to mediate target gene expression in HCC are known. In order to characterize BMP expression pattern in HCC cell lines, we performed RT-PCR analysis and revealed enhanced expression levels of several BMPs (BMP4, 6, 7, 8, 9, 10, 11, 13 and 15) in HCC. Thus, we treated HCC cells with the general BMP inhibitors chordin and noggin to determine the functional relevance of BMP overexpression and observed decreased migration and invasion of HCC cells. A cDNA microarray of noggin treated HCC cells was performed to analyze downstream targets of BMPs mediating these oncogenic functions. Subsequent analysis identified collagen XVI as 'Smad signaling specific' and nidogen-2 as 'MAPK/ERK signaling specific' BMP-target genes. To examine which signaling pathway is mainly responsible for the oncogenic role of BMPs in HCC, we treated HCC cells with dorsomorphin to determine the influence of BMP activated Smad signaling. Interestingly, also migratory and invasive behavior of dorsomorphin treated HCC cells was diminished. In summary, our findings demonstrate enhanced expression levels of several BMPs in HCC supporting enhanced migratory and invasive phenotype of HCC cells mainly via activation of Smad signaling. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22024355     DOI: 10.1016/j.yexmp.2011.10.004

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  24 in total

Review 1.  Starvation and Pseudo-Starvation as Drivers of Cancer Metastasis through Translation Reprogramming.

Authors:  Custodia García-Jiménez; Colin R Goding
Journal:  Cell Metab       Date:  2018-12-20       Impact factor: 27.287

Review 2.  Collagen biology making inroads into prognosis and treatment of cancer progression and metastasis.

Authors:  Ana C Martins Cavaco; Sara Dâmaso; Sandra Casimiro; Luís Costa
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

3.  Dihydromyricetin inhibits migration and invasion of hepatoma cells through regulation of MMP-9 expression.

Authors:  Qing-Yu Zhang; Ran Li; Guo-Fang Zeng; Bin Liu; Jie Liu; Yang Shu; Zhong-Kao Liu; Zhi-Dong Qiu; Dong-Jun Wang; Hui-Lai Miao; Ming-Yi Li; Run-Zhi Zhu
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

4.  SMAD4 exerts a tumor-promoting role in hepatocellular carcinoma.

Authors:  P Y Hernanda; K Chen; A M Das; K Sideras; W Wang; J Li; W Cao; S J A Bots; L L Kodach; R A de Man; J N M Ijzermans; H L A Janssen; A P Stubbs; D Sprengers; M J Bruno; H J Metselaar; T L M ten Hagen; J Kwekkeboom; M P Peppelenbosch; Q Pan
Journal:  Oncogene       Date:  2014-12-22       Impact factor: 9.867

5.  BMPER regulates cardiomyocyte size and vessel density in vivo.

Authors:  Monte S Willis; Laura A Dyer; Rongqin Ren; Pamela Lockyer; Isabel Moreno-Miralles; Jonathan C Schisler; Cam Patterson
Journal:  Cardiovasc Pathol       Date:  2012-11-28       Impact factor: 2.185

6.  DMH1, a small molecule inhibitor of BMP type i receptors, suppresses growth and invasion of lung cancer.

Authors:  Jijun Hao; Rachel Lee; Andy Chang; Jeffery Fan; Chantelle Labib; Cyrus Parsa; Robert Orlando; Bradley Andresen; Ying Huang
Journal:  PLoS One       Date:  2014-03-06       Impact factor: 3.240

Review 7.  Potential roles of bone morphogenetic protein (BMP)-9 in human liver diseases.

Authors:  Blanca Herrera; Steven Dooley; Katja Breitkopf-Heinlein
Journal:  Int J Mol Sci       Date:  2014-03-25       Impact factor: 5.923

8.  Romidepsin hepatocellular carcinoma suppression in mice is associated with deregulated gene expression of bone morphogenetic protein and Notch signaling pathway components.

Authors:  Hara Afaloniati; Theofilos Poutahidis; Alexander Giakoustidis; Athanasios Gargavanis; Dimitrios Giakoustidis; Katerina Angelopoulou
Journal:  Mol Biol Rep       Date:  2021-01-03       Impact factor: 2.316

9.  FSTL3 is a Prognostic Biomarker in Gastric Cancer and is Correlated with M2 Macrophage Infiltration.

Authors:  Yuan-Jie Liu; Jie-Pin Li; Ying Zhang; Meng-Jun Nie; Yong-Hua Zhang; Shen-Lin Liu; Xi Zou
Journal:  Onco Targets Ther       Date:  2021-07-06       Impact factor: 4.147

10.  BMP9 is a proliferative and survival factor for human hepatocellular carcinoma cells.

Authors:  Blanca Herrera; María García-Álvaro; Silvia Cruz; Peter Walsh; Margarita Fernández; Cesáreo Roncero; Isabel Fabregat; Aránzazu Sánchez; Gareth J Inman
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.